Elicera invites to investor meetings on February 28[th] and 29[th] 2024

In connection with the upcoming rights issue in Elicera Therapeutics AB (publ) ("Elicera" or "the Company"), the Company invites shareholders and the public to an investor meeting in Stockholm and a digital investor meeting.

Elicera's CEO, Jamal El-Mosleh, will present the Company on two occasions. The first occasion is on Wednesday, February 28th, at 4:00 PM and will be held digitally via Microsoft Teams. The second occasion is on Thursday, February 29th, at 12:00 PM and will be held at Mangold Fondkommission’s premises at Nybrogatan 55, where lunch will also be provided. Do note that both meetings will be held in Swedish.

To participate in any of Elicera's investor meetings, please register by sending an email to [email protected] no later than 3:00 PM on February 27th, 2024.

For more information regarding the rights issue, please visit Elicera's website at www.elicera.com.